Novo CEO pressed by Senate to cut costs of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would take into account new talks with insurers with regards to the list costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own https://rowanovsni.blog2news.com/31246064/facts-about-healthcare-news-revealed